Congenital hypothyroidism, the first cause of preventable mental retardation: a challenge for preventive medicine
PDF (Español (España))
HTML (Español (España))

How to Cite

Ojeda-Rincón, S. A., Gualdrón-Rincón, Édgar F., García-Rueda, N. A., Sarmiento-Villamizar, D. F., Parada-Botello, N. S., Gelves-Díaz, S. A., & Rubio-Guerrero, G. R. (2016). Congenital hypothyroidism, the first cause of preventable mental retardation: a challenge for preventive medicine. Médicas UIS, 29(1), 53–60. https://doi.org/10.18273/revmed.v29n1-2016006

Abstract

ABSTRACT

Congenital hypothyroidism is the most common endocrine disease in newborns and can be clinical or subclinical. It is the leading cause of treatable mental retardation and its prognosis is in the early screening and timely initiation of treatment; this is the reason why in Colombia the implementation of a neonatal screening with appropriate national coverage technique, comparable to those in other countries, is considered necessary. The aim of this article is to review and analyse the literature on congenital hypothyroidism focused on the definition, epidemiology, etiological factors, screening, diagnosis and treatment; by search in PubMed, EMBASE, REDALYC, OVID, MEDLINE, and CLINICAL KEY Dynamed data (access: May 2015). Besides reviewing the reports of the National Institute of Health in 2013 and 2014, the European guidelines for pediatric endocrinology society of 2014, Mexico’s 2008 guide neonatal congenital hypothyroidism and Colombian consensus for the diagnosis and management of thyroid diseases. MÉD UIS. 2016;29(1):53-60.

Keywords: Congenital hypothyroidism. Neonatal screening. Epidemiology.

https://doi.org/10.18273/revmed.v29n1-2016006
PDF (Español (España))
HTML (Español (España))

References

Radwin, L. S., Michelson, J. P., Berman, A. B. & Kramer, B. End results in treatment of congenital hypothyroidism; follow-up study of physical, mental and behavioral development. Am J Dis Child. 1949;78(6):821-43.

Fisher, D. A. et al. Screening for congenital hypothyroidism: results of screening one million North American infants. J Pediatr. 1979;94(5):700–5.

Illig, R. & Gitzelmann, R. Screening for congenital hypothyroidism. J Pediatr. 1977;91(2):348–9.

Clerc, J. et al. Scintigraphic imaging of paediatric thyroid dysfunction. Horm Res. 2008;70(1):1–13.

Bubuteishvili, L., Garel, C., Czernichow, P.& Léger, J. Thyroid abnormalities by ultrasonography in neonates with congenital hypothyroidism. J Pediatr. 2003; 143(6):759–64.

Marinovic, D., Garel, C., Czernichow, P. & Léger, J. Ultrasonographic assessment of the ectopic thyroid tissue in children with congenital hypothyroidism. Pediatr Radiol. 2004;34(2):109–13.

Bermúdez AJ, Hernández LS, González NE. Tamizaje neonatal de hipotiroidismo congénito, vigilancia por el laboratorio. Ministerio de la protección social, Instituto Nacional de Salud, 2004.

Fullana A, Barona-Vilar C. Cribado neonatal del hipotiroidismo congénito. Una gran aportación a la salud pública de las últimas décadas. Med Clin (Barc). 2010; 134(7):307–9.

Misnaza SP, Garzón FE. Informe del evento hipotiroidismo congénito hasta el periodo epidemiológico tres del año 2014. Instituto Nacional de Salud, 2012, Versión 01, pág. 1-14.

E Mayayo Dehesa. Hipotiroidismo y bocio. Protoc Diagn Ter Pediatr. 2011;1:150-65.

Léger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet H, et al. European Society for Paediatric Endocrinology Consensus Guidelines on Screening, Diagnosis, and Management of Congenital Hypothyroidism. J Clin Endocrinol Metab. 2014;99(2): 363–84.

Chen X, Yu-Feng Q, Xue-Lian Z, Ru-Lai Y, Yu-Hua S, Hua-Qing M, et al. Diagnosis and treatment of subclinical hypothyroidism detected by neonatal screening. World J Pediatr. 2011; 7(4):350-4.

Stoppa S, Van G, Deladoëy J. Variation by ethnicity in the prevalence of congenital Hypothyroidism due to thyroid dysgenesis. Thyroid. 2011; 21(1):13-8.

Toublanc J. Comparision of epidemiological data on congenital hypothyroidism in Europe with those of other parts in the world. Horm Res. 1992; 38(5-6):230-5.

Felice M, Lauro R. Thyroid Development and Its Disorders: Genetics and Molecular Mechanisms. Endocr Rev. 2004; 25(5):722-46.

Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis. 2010;5(17):1-22.

Marrero-González N, González E, Frómeta A, Baloy A, Castells E, Pérez P, et al. Influencia de la edad en los resultados del cribado neonatal. Rev Mex Patol Clin. 2004;51(4):220-5.

Martinez M, Orozco M. Hipotiroidismo Congénito. Reporte de un Caso Diagnosticado por Tamiz Neonatal. Bol Clin Hosp Infant Edo Son. 2008;25(2):115-8.

Thvillum M, Brandt F, Hegedüs T. A review of the evidence for and against increased mortality in hypothyroidism. Nat. Rev.Endocrinol. 2012;8:417-24.

Centro Nacional de Excelencia Tecnológica en Salud. Prevención, diagnóstico y tratamiento del hipotiroidismo congénito neonatal en el primer nivel de atención. México: CENETEC;2008.

Razavi Z, Yavarikia A, Torabian S. Congenital Anomalies in Infant with Congenital Hypothyroidism. Oman Med J. 2012;27(5):364-7.

Purdy IB, Singh N, Brown WL, Vangala S, Devaskar UP. Revisiting early hypothyroidism screening in infants with Down syndrome. J Perinatol. 2014;34(12):936-40

Rose S, Brown R, Foley T, Kaplowitz P, Sundararajan S, Varma S, et al. Update of newborn Screening and Teraphy for Congenital Hypothyroidism. Pediatrics. 2006;117(6):2290-303

Rodriguez G, Assad J, García M, Arias M, Zapata M. Factores que influyen en el diagnóstico e inicio de tratamiento, oportuno en el hipotiroidismo congénito. Pediatr Mex. 1999;1.2(7):19-24.

Liu S, Zhang S, Li W, Zhang A, Qi F, Zheng G, et al. Clinical and Genetic Analysis of a Compound Heterozygous Mutation in the Thyroglobulin Gene in a Chinese Twin Family With Congenital Goiter and Hypothyroidism. Twin Res Hum Genet. 2012;15(1):126-32.

Bermúdez AJ, Hernández LS, González NE. Tamizaje neonatal de hipotiroidismo congénito, vigilancia por el laboratorio. Colombia:

Instituto Nacional de Salud; 2004.

Nair P, Sobhakumar S, Kailas L. Diagnostic Re-evaluation of Children with Congenital Hypothyroidism. Indian Pediatr. 2010;47(9):757-60

Bermúdez A, Gonzales N, Rosero M, Escobar J. Protocolo de vigilancia del hipotiroidismo congénito.Colombia: Instituto Nacional de Salud;2008

Bernal M, Caldas M, Bonilla R, Chamorro G, Matallana A. Tamización para hipotiroidismo congénito en Cali y constitución de un centro piloto de referencia para la identificación temprana de la enfermedad. Colomb Med. 2003;34(1):40-6

Vanegas N. Prevalencia de Hipotiroidismo congénito diagnosticado con tamizaje en recién nacidos del Hospital San Rafael de Bogotá entre el año 2010 al 2011. [Tesis de posgrado]. Bogotá D.C.: Universidad Militar Nueva Granada; 2012.

Gobernación del Tolima, secretaria de salud departamental dirección de salud pública. Tamizaje neonatal para hipotiroidismo congénito.

Martínez SN, Morales P, Hernández MG. Caso clínico: Hipotiroidismo congénito, diagnóstico oportuno. Rev Invest Med Sur Mex. 2012; 19(3): 184-6.

Grob LF, Martínez-Aguayo A. Hipotiroidismo congénito: un diagnóstico que no debemos olvidar. Rev Chil Pediatr. 2012;83(5): 482-91.

Adeniran, K. A, Limbe M. Review Article on Congenital Hypothyroidism and Newborn Screening Program in Africa; the Present Situation and the Way Forward. Thyroid Disorders Ther. 2012; 1(102):1-4.

Pitt, J. Newborn Screening. Clin Biochem Rev. 2010; 31(2):57-68.

Sanghvi U, Diwakar KK. Universal Newborn Screening for Congenital Hypothyroidism. Indian J Pediatr. 2008; 45(4)331-2.

Misnaza SP. Informe final hipotiroidismo congénito del año 2013. Instituto Nacional de Salud vigilancia y control en salud pública. 2012; versión 01:1-16.

Grüters A, Krude H. Detection and treatment of congenital hypothyroidism. Nat Rev Endocrinol. 2012; 8(2):104–13.

Goel P, Kahkasha, Narang S, Gupta BK, Goel K. Evaluation of Serum Prolactin Level in Patients of Subclinical and Overt hypothyroidism. J Clin Diagn Res. 2015 ;9(1):BC15-7

González V, Santucci Z, Pattin J, Apezteguía M, Borrajo G. Programa de pesquisa neonatal de hipotiroidismo congénito de la provincia de Buenos Aires: 1.377.455 niños evaluados en diez años de experiencia. Arch Argent Pediatr. 2007; 105(5):390-7.

Zeinalzadeh A, Talebi M. Neonatal screening for congenital hypothyroidism in East Azerbaijan, Iran: the first report. J Med Screen. 2012;19(3):123–6

Osborn, DA. Hunt, RW. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2007; 24(1):CD005948.

Asociación Colombiana de Endocrinología Santafé de Bogotá, Colombia. Consenso colombiano para el diagnóstico y manejo de enfermedades tiroideas. Acta Med Colomb. 1999;(24):4 159-74.

Alexander E, Marqusee E, Jennifer L ,Jarolim P. Fsicher G, Reed Larsen P. Timing and Magnitude of Increases in Levothyroxine Requirements during Pregnancy in Women with Hypothyroidism. N Engl J Me. 2004; (351):241-9.

The National Health Service (NHS) UK Newborn Screening Programme Centre’s Health Professional Handbook.2012;(1):5-46.

Grosse SD, Van Vliet G. Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level?. Arch Dis Child. 2011;96(4):374-9.

Cameo T, Gumer LB, Williams KM, Gomez J, McMahon DJ, Oberfield SE. A retrospective review of newborn screening for congenital hypothyroidism and newborn thyroid disease at a major medical center. Clin Pediatr (Phila). 2013;52(11):1054-8.

Marti S, Alvarez M, Simoneau-Roy J, Leroux S, Van Vliet G, Robaey P. Effects of early high-dose levothyroxine treatment on auditory brain event-related potentials at school entry in children with congenital hypothyroidism. Horm Res. 2006;66(5):240–8.

Cassio A, Cacciari E, Cicognani A, Damiani G, Missiroli G, Corbelli E, et al. Treatment for Congenital Hypothyroidism: Thyroxine Alone or Thyroxine Plus Triiodothyronine?. Pediatrics. 2003;111(5 Pt 1):1005-1060.

Marrero N, Rodríguez C. Hipotiroidismo Congénito: historia e impacto del tamizaje. Rev Biomed. 2000;11(4):283-92.

Downloads

Download data is not yet available.